MSCLF Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:MSCLF

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 26, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$MSCLF N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Satellos Bioscience Inc. Loading... Loading...
Sector Name Loading... N/A

Related

IPCIFIntellipharmaceutics International Inc.0.0%
ATBPFAntibe Therapeutics Inc.13.5%
TBPMFTetra Bio-Pharma Inc.-26.5%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue0M0M0M0M0M
Growth Rate--100.0%0.0%0.0%0.0%
EBITDA-2M-2M-5M-8M-15M
EBITDA Margin-8,810.4%0.0%0.0%0.0%0.0%
Net Income-2M-2M-16M-11M-16M
NI Margin-7,752.9%0.0%0.0%0.0%0.0%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.